124 related articles for article (PubMed ID: 30522551)
1. GLP-1 attenuates Ang II-induced proliferation and migration in rat aorta smooth muscle cells
Xiong QF; Fan SH; Zhang X; Niu Y; Li XW; Shi YW; Zhang LH
Pharmazie; 2018 Dec; 73(12):692-699. PubMed ID: 30522551
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.
Nagayama K; Kyotani Y; Zhao J; Ito S; Ozawa K; Bolstad FA; Yoshizumi M
PLoS One; 2015; 10(9):e0137960. PubMed ID: 26379274
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway.
Li N; Cai R; Niu Y; Shen B; Xu J; Cheng Y
Int J Mol Med; 2012 Oct; 30(4):811-8. PubMed ID: 22842919
[TBL] [Abstract][Full Text] [Related]
4. Trapidil inhibits platelet-derived growth factor-induced migration via protein kinase A and RhoA/Rho-associated kinase in rat vascular smooth muscle cells.
Ishikura K; Fujita H; Hida M; Awazu M
Eur J Pharmacol; 2005 May; 515(1-3):28-33. PubMed ID: 15894306
[TBL] [Abstract][Full Text] [Related]
5. TMEM16A contributes to angiotensin II-induced cerebral vasoconstriction via the RhoA/ROCK signaling pathway.
Li RS; Wang Y; Chen HS; Jiang FY; Tu Q; Li WJ; Yin RX
Mol Med Rep; 2016 Apr; 13(4):3691-9. PubMed ID: 26955761
[TBL] [Abstract][Full Text] [Related]
6. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 1 reverses myocardial hypertrophy through cAMP/PKA/RhoA/ROCK2 signaling.
Fan S; Xiong Q; Zhang X; Zhang L; Shi Y
Acta Biochim Biophys Sin (Shanghai); 2020 Jun; 52(6):612-619. PubMed ID: 32386193
[TBL] [Abstract][Full Text] [Related]
8. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
9. Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
Zhou Q; Wei SS; Wang H; Wang Q; Li W; Li G; Hou JW; Chen XM; Chen J; Xu WP; Li YG; Wang YP
Hypertension; 2017 Jun; 69(6):1070-1083. PubMed ID: 28438902
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells.
Dong X; Yu LG; Sun R; Cheng YN; Cao H; Yang KM; Dong YN; Wu Y; Guo XL
J Cell Biochem; 2013 Jan; 114(1):174-82. PubMed ID: 22887358
[TBL] [Abstract][Full Text] [Related]
12. Progesterone induces RhoA Inactivation in male rat aortic smooth muscle cells through up-regulation of p27(kip1.).
Wang HC; Lee WS
Endocrinology; 2014 Nov; 155(11):4473-82. PubMed ID: 25137028
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide inhibits angiotensin II-induced proliferation and migration of pulmonary arterial smooth muscle cells.
Hsu JH; Liou SF; Yang SN; Wu BN; Dai ZK; Chen IJ; Yeh JL; Wu JR
Pediatr Pulmonol; 2014 Aug; 49(8):734-44. PubMed ID: 24167111
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
[TBL] [Abstract][Full Text] [Related]
15. Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells.
Moraes JA; Frony AC; Dias AM; Renovato-Martins M; Rodrigues G; Marcinkiewicz C; Assreuy J; Barja-Fidalgo C
Atherosclerosis; 2015 Dec; 243(2):477-85. PubMed ID: 26520903
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 inhibits vascular smooth muscle cell dedifferentiation through mitochondrial dynamics regulation.
Torres G; Morales PE; García-Miguel M; Norambuena-Soto I; Cartes-Saavedra B; Vidal-Peña G; Moncada-Ruff D; Sanhueza-Olivares F; San Martín A; Chiong M
Biochem Pharmacol; 2016 Mar; 104():52-61. PubMed ID: 26807480
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p90RSK is critical to abolish Angiotensin II-induced rat aortic smooth muscle cell proliferation and migration.
Huynh DTN; Jin Y; Myung CS; Heo KS
Biochem Biophys Res Commun; 2020 Feb; 523(1):267-273. PubMed ID: 31864701
[TBL] [Abstract][Full Text] [Related]
18. cAMP attenuates angiotensin-II-induced Egr-1 expression via PKA-dependent signaling pathway in vascular smooth muscle cells.
Simo-Cheyou ER; Youreva V; Srivastava AK
Can J Physiol Pharmacol; 2017 Aug; 95(8):928-937. PubMed ID: 28460186
[TBL] [Abstract][Full Text] [Related]
19. Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation.
Seo J; Lee HS; Ryoo S; Seo JH; Min BS; Lee JH
Eur J Pharmacol; 2011 Dec; 673(1-3):56-64. PubMed ID: 22040922
[TBL] [Abstract][Full Text] [Related]
20. Rho-associated protein kinase isoforms stimulate proliferation of vascular smooth muscle cells through ERK and induction of cyclin D1 and PCNA.
Zhao Y; Lv M; Lin H; Cui Y; Wei X; Qin Y; Kohama K; Gao Y
Biochem Biophys Res Commun; 2013 Mar; 432(3):488-93. PubMed ID: 23402758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
